2023
DOI: 10.1038/s41581-023-00736-7
|View full text |Cite
|
Sign up to set email alerts
|

Inflammation and gut dysbiosis as drivers of CKD–MBD

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(5 citation statements)
references
References 212 publications
0
5
0
Order By: Relevance
“…These results may indicate a link between microbiota and VC in CKD patients on peritoneal dialysis [ 52 ] ( Table 1 ). Such results from similar studies led to the hypothesis that inflammation and gut dysbiosis are important drivers of CKD–MBD [ 85 ]. An association between dietary inflammatory index and cardiovascular disease and mortality was recently proven [ 86 ].…”
Section: Uremic Toxins Microbiota Fibers and Vascular Calcification I...mentioning
confidence: 99%
“…These results may indicate a link between microbiota and VC in CKD patients on peritoneal dialysis [ 52 ] ( Table 1 ). Such results from similar studies led to the hypothesis that inflammation and gut dysbiosis are important drivers of CKD–MBD [ 85 ]. An association between dietary inflammatory index and cardiovascular disease and mortality was recently proven [ 86 ].…”
Section: Uremic Toxins Microbiota Fibers and Vascular Calcification I...mentioning
confidence: 99%
“…Both small and large uremic toxins and especially protein-bound uremic toxins predispose CKD or HD patients to uremic VC [ 53 ]. Uremia promotes intestinal dysbiosis and disrupts the intestinal epithelial barrier [ 54 ], thus allowing live bacteria, endotoxins (lipopolysaccharide), and gut-derived uremic toxins to enter the systemic circulation, a condition commonly known as “leaky gut” [ 55 ]. In CKD, the pathogenesis of a leaky gut is a multifactorial process driven by sympathetic hyperactivity, intestinal congestion, hypogonadism, increased urine ammonia and ammonium hydroxide exposure, and decreased butyrate production [ 55 ].…”
Section: Reviewmentioning
confidence: 99%
“…Finally, increased intestinal permeability is caused by altered zonulin expression. Hence, the use of the zonulin antagonist larazotide may improve the integrity of the intestinal barrier, thereby reducing the absorption of toxins [ 55 ]. Given that numerous vasotoxic compounds are derived from gut microbiota-mediated metabolism, the gut is increasingly recognized as a promising target for therapy [ 57 ].…”
Section: Reviewmentioning
confidence: 99%
“…Among all the adverse outcomes caused by CKD, cardiovascular disease (CVD), as a leading cause of death, is one of the most important and severe (2,4,5). Patients with CKD typically present with hypertension, atherosclerosis, lipid metabolism abnormalities, mineral and bone disorders, chronic inflammation, and oxidative stress (6)(7)(8)(9)(10)(11)(12). These alterations commonly result from a decline in the glomerular filtration rate (9).…”
Section: Introductionmentioning
confidence: 99%
“…Patients with CKD typically present with hypertension, atherosclerosis, lipid metabolism abnormalities, mineral and bone disorders, chronic inflammation, and oxidative stress (6)(7)(8)(9)(10)(11)(12). These alterations commonly result from a decline in the glomerular filtration rate (9). Notably, chronic inflammation and oxidative stress can exacerbate endothelial damage, leading to the formation of unstable atherosclerotic plaques (6,(13)(14)(15).…”
Section: Introductionmentioning
confidence: 99%